Global Non-Hematological Cancers Markets Are Forecast to Grow at a CAGR of 9.86%, from $73 Billion in 2014 to $141 Billion in 2021
In 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis, non-hematological cancers are thought to account for 94% of global cancer prevalence. The key cancer indications of this report, namely breast, colorectal, lung and prostate cancer, constitute approximately 51% of global cancer prevalence.
View full press release